TY - JOUR
T1 - Sequential Metabolism of 7-Dehydrocholesterol to Steroidal 5,7-Dienes in Adrenal Glands and Its Biological Implication in the Skin
AU - Slominski, A.T.
AU - Zmijewski, M.A.
AU - Semak, I.
AU - Sweatman, T.
AU - Janjetovic, Z.
AU - Li, W.
AU - Zjawiony, J.K.
AU - Tuckey, Robert
PY - 2009
Y1 - 2009
N2 - Since P450scc transforms 7-dehydrocholesterol (7DHC) to 7-dehydropregnenolone (7DHP) in vitro, we investigated sequential7DHC metabolism by adrenal glands ex vivo. There was a rapid, time- and dose-dependent metabolism of 7DHC by adrenalsfrom rats, pigs, rabbits and dogs with production of more polar 5,7-dienes as detected by RP-HPLC. Based on retention time(RT), UV spectra and mass spectrometry, we identified the major products common to all tested species as 7DHP, 22-hydroxy-7DHC and 20,22-dihydroxy-7DHC. The involvement of P450scc in adrenal metabolic transformation was confirmed by theinhibition of this process by DL-aminoglutethimide. The metabolism of 7DHC with subsequent production of 7DHP wasstimulated by forscolin indicating involvement of cAMP dependent pathways. Additional minor products of 7DHC metabolismthat were more polar than 7DHP were identified as 17-hydroxy-7DHP (in pig adrenals but not those of rats) and as pregna-4,7-diene-3,20-dione (7-dehydroprogesterone). Both products represented the major identifiable products of 7DHP metabolism inadrenal glands. Studies with purified enzymes show that StAR protein likely transports 7DHC to the inner mitochondrialmembrane, that 7DHC can compete effectively with cholesterol for the substrate binding site on P450scc and that the catalyticefficiency of 3bHSD for 7DHP (Vm/Km) is 40% of that for pregnenolone. Skin mitochondria are capable of transforming 7DHC to7DHP and the 7DHP is metabolized further by skin extracts. Finally, 7DHP, its photoderivative 20-oxopregnacalciferol, andpregnenolone exhibited biological activity in skin cells including inhibition of proliferation of epidermal keratinocytes andmelanocytes, and melanoma cells. These findings define a novel steroidogenic pathway: 7DHCR22(OH)7DHCR20,22(OH)27DHCR7DHP, with potential further metabolism of 7DHP mediated by 3bHSD or CYP17, depending onmammalian species. The 5–7 dienal intermediates of the pathway can be a source of biologically active vitamin D3 derivativesafter delivery to or production in the skin, an organ intermittently exposed to solar radiation.
AB - Since P450scc transforms 7-dehydrocholesterol (7DHC) to 7-dehydropregnenolone (7DHP) in vitro, we investigated sequential7DHC metabolism by adrenal glands ex vivo. There was a rapid, time- and dose-dependent metabolism of 7DHC by adrenalsfrom rats, pigs, rabbits and dogs with production of more polar 5,7-dienes as detected by RP-HPLC. Based on retention time(RT), UV spectra and mass spectrometry, we identified the major products common to all tested species as 7DHP, 22-hydroxy-7DHC and 20,22-dihydroxy-7DHC. The involvement of P450scc in adrenal metabolic transformation was confirmed by theinhibition of this process by DL-aminoglutethimide. The metabolism of 7DHC with subsequent production of 7DHP wasstimulated by forscolin indicating involvement of cAMP dependent pathways. Additional minor products of 7DHC metabolismthat were more polar than 7DHP were identified as 17-hydroxy-7DHP (in pig adrenals but not those of rats) and as pregna-4,7-diene-3,20-dione (7-dehydroprogesterone). Both products represented the major identifiable products of 7DHP metabolism inadrenal glands. Studies with purified enzymes show that StAR protein likely transports 7DHC to the inner mitochondrialmembrane, that 7DHC can compete effectively with cholesterol for the substrate binding site on P450scc and that the catalyticefficiency of 3bHSD for 7DHP (Vm/Km) is 40% of that for pregnenolone. Skin mitochondria are capable of transforming 7DHC to7DHP and the 7DHP is metabolized further by skin extracts. Finally, 7DHP, its photoderivative 20-oxopregnacalciferol, andpregnenolone exhibited biological activity in skin cells including inhibition of proliferation of epidermal keratinocytes andmelanocytes, and melanoma cells. These findings define a novel steroidogenic pathway: 7DHCR22(OH)7DHCR20,22(OH)27DHCR7DHP, with potential further metabolism of 7DHP mediated by 3bHSD or CYP17, depending onmammalian species. The 5–7 dienal intermediates of the pathway can be a source of biologically active vitamin D3 derivativesafter delivery to or production in the skin, an organ intermittently exposed to solar radiation.
U2 - 10.1371/journal.pone.0004309
DO - 10.1371/journal.pone.0004309
M3 - Article
C2 - 19190754
SN - 1932-6203
VL - 4
SP - Article number e4309, 18pp
JO - PLoS One
JF - PLoS One
IS - 2
ER -